Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries

BACKGROUND AND AIMS: For children with heterozygous familial hypercholesterolaemia (HeFH), European guidelines recommend consideration of statin therapy by age 8–10 years for those with a low density lipoprotein cholesterol (LDL-C) >3.5 mmol/l, and dietary and lifestyle advice. Here we compare th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Atherosclerosis
Päätekijät: Ramaswami, Uma, Futema, Marta, Bogsrud, Martin P., Holven, Kirsten B., Roeters van Lennep, Jeanine, Wiegman, Albert, Descamps, Olivier S., Vrablik, Michal, Freiberger, Tomas, Dieplinger, Hans, Greber-Platzer, Susanne, Hanauer-Mader, Gabriele, Bourbon, Mafalda, Drogari, Euridiki, Humphries, Steve E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6949888/
https://ncbi.nlm.nih.gov/pubmed/31809987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2019.11.012
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia